Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(20 sites)
United States
University of Michigan Health - Michigan Medicine - University Hospital-Investigational Site Number: 8400001, Ann Arbor, Michigan Mayo Clinic_Investigational Site Number: 8400009, Rochester, Minnesota New York Oncology Hematology_Investigational Site Number: 8400010, Albany, New York Montefiore Medical Center-Investigational Site Number: 8400012, The Bronx, New York Community Cancer Trials of Utah_Investigational Site Number: 8400002, Ogden, Utah Austria
Investigational Site Number : 0400001, Vienna France
Investigational Site Number: 2500003, Créteil Investigational Site Number : 2500001, Dijon Investigational Site Number : 2500002, Pessac Investigational Site Number : 2500004, Toulouse Hungary
Investigational Site Number : 3480002, Kaposvár Italy
Investigational Site Number : 3800006, Naples Investigational Site Number : 3800003, Vicenza Poland
Investigational Site Number : 6160002, Gdansk Investigational Site Number : 6160003, Skorzewo Investigational Site Number : 6160004, Słupsk Spain
Investigational Site Number : 7240002, Burgos Investigational Site Number : 7240008, Madrid Investigational Site Number : 7240005, Murcia Investigational Site Number : 7240004, Seville